Urogen Pharma Balance Sheet
Urogen Pharma's total assets for Q4 2025 were $200.46M, an increase of 8.33% from the previous quarter. URGN total liabilities were $305.93M for the fiscal quarter, a 1.82% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.